These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 18326741
41. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion. Sohn HJ, Han DH, Lee DY, Nam DH. Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803 [Abstract] [Full Text] [Related]
42. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion. Zhang Y, Fortune B, Atchaneeyasakul LO, McFarland T, Mose K, Wallace P, Main J, Wilson D, Appukuttan B, Stout JT. Curr Eye Res; 2008 Apr; 33(4):365-76. PubMed ID: 18398711 [Abstract] [Full Text] [Related]
43. In Vivo Retinal Vein Bypass Surgery in a Porcine Model. Shen LJ, Chen YQ, Cheng D, Zhang C, Jiang L, Hong M, Kang QY. Curr Eye Res; 2016 Apr; 41(1):79-87. PubMed ID: 25549290 [Abstract] [Full Text] [Related]
44. Acute variations in retinal vascular oxygen content in a rabbit model of retinal venous occlusion. Jaime GR, Kashani AH, Saati S, Martin G, Chader G, Humayun MS. PLoS One; 2012 Apr; 7(11):e50179. PubMed ID: 23185567 [Abstract] [Full Text] [Related]
45. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C. Ophthalmologica; 2012 Apr; 228(2):110-6. PubMed ID: 22739239 [Abstract] [Full Text] [Related]
46. Decreased nitric oxide production accounts for secondary arteriolar constriction after retinal branch vein occlusion. Donati G, Pournaras CJ, Pizzolato GP, Tsacopoulos M. Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1450-7. PubMed ID: 9191609 [Abstract] [Full Text] [Related]
47. Morphologic and functional changes in retinal vessels associated with branch retinal vein occlusion. Muraoka Y, Tsujikawa A, Murakami T, Ogino K, Kumagai K, Miyamoto K, Uji A, Yoshimura N. Ophthalmology; 2013 Jan; 120(1):91-9. PubMed ID: 22980743 [Abstract] [Full Text] [Related]
48. Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment. Kaneda S, Miyazaki D, Sasaki S, Yakura K, Terasaka Y, Miyake K, Ikeda Y, Funakoshi T, Baba T, Yamasaki A, Inoue Y. Invest Ophthalmol Vis Sci; 2011 May 06; 52(6):2982-8. PubMed ID: 21273540 [Abstract] [Full Text] [Related]
49. Serous macular detachment in branch retinal vein occlusion. Yamaguchi Y, Otani T, Kishi S. Retina; 2006 May 06; 26(9):1029-33. PubMed ID: 17151490 [Abstract] [Full Text] [Related]
50. Dorzolamide effect on ocular blood flow. Martinez A, Gonzalez F, Capeans C, Perez R, Sanchez-Salorio M. Invest Ophthalmol Vis Sci; 1999 May 06; 40(6):1270-5. PubMed ID: 10235564 [Abstract] [Full Text] [Related]
51. Pathophysiology and hemodynamics of branch retinal vein occlusion. Christoffersen NL, Larsen M. Ophthalmology; 1999 Nov 06; 106(11):2054-62. PubMed ID: 10571337 [Abstract] [Full Text] [Related]
52. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Retina; 2013 May 06; 33(5):901-10. PubMed ID: 23609064 [Abstract] [Full Text] [Related]
53. Study of retinal vessel oxygen saturation in ischemic and non-ischemic branch retinal vein occlusion. Lin LL, Dong YM, Zong Y, Zheng QS, Fu Y, Yuan YG, Huang X, Qian G, Gao QY. Int J Ophthalmol; 2016 May 06; 9(1):99-107. PubMed ID: 26949618 [Abstract] [Full Text] [Related]
54. Effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate and intraocular pressure in clinically normal cats. Rankin AJ, Crumley WR, Allbaugh RA. Am J Vet Res; 2012 Jul 06; 73(7):1074-8. PubMed ID: 22738060 [Abstract] [Full Text] [Related]
55. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Strohmaier K, Snyder E, DuBiner H, Adamsons I. Ophthalmology; 1999 Dec 06; 106(12 Suppl):1-9. PubMed ID: 10598691 [Abstract] [Full Text] [Related]
56. [Patterns of arteriovenous crossings in branch retinal vein occlusion]. Du ZY, Tan JQ, Jiang DY. Zhonghua Yan Ke Za Zhi; 1994 Sep 06; 30(5):345-7. PubMed ID: 7805535 [Abstract] [Full Text] [Related]
57. Association of inflammatory factors with macular edema in branch retinal vein occlusion. Noma H, Mimura T, Eguchi S. JAMA Ophthalmol; 2013 Feb 06; 131(2):160-5. PubMed ID: 23411880 [Abstract] [Full Text] [Related]
58. [Role of the vitreous in retinal neovascularization evaluated by a comparison of central retinal vein occlusion and branch retinal vein occlusion]. Kado M, Hirokawa H, Yoshida A. Nippon Ganka Gakkai Zasshi; 1989 Aug 06; 93(8):812-6. PubMed ID: 2610160 [Abstract] [Full Text] [Related]
59. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Koss MJ, Pfister M, Rothweiler F, Michaelis M, Cinatl J, Schubert R, Koch FH. Acta Ophthalmol; 2012 Mar 06; 90(2):e98-e103. PubMed ID: 22066978 [Abstract] [Full Text] [Related]
60. Retinal vessel oxygen saturation in healthy subjects and early branch retinal vein occlusion. Yang JY, You B, Wang Q, Chan SY, Jonas JB, Wei WB. Int J Ophthalmol; 2017 Mar 06; 10(2):267-270. PubMed ID: 28251087 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]